![]() |
Volumn 89, Issue 7, 2001, Pages
|
Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOLIPOPROTEIN E;
COMPLEMENTARY DNA;
GLYCOPROTEIN;
INTERLEUKIN 18;
INTERLEUKIN 18 BINDING PROTEIN;
INTERLEUKIN-18 BINDING PROTEIN;
SIGNAL PEPTIDE;
ANIMAL;
AORTA SINUS;
ARTERIOSCLEROSIS;
ARTICLE;
C57BL MOUSE;
DISEASE COURSE;
DISEASE MODEL;
DRUG ANTAGONISM;
DRUG EFFECT;
ELECTROPORATION;
GENE THERAPY;
GENETICS;
INTRAMUSCULAR DRUG ADMINISTRATION;
MALE;
METHODOLOGY;
MOUSE;
MOUSE MUTANT;
PATHOLOGY;
PHENOTYPE;
PLASMID;
SIGNAL TRANSDUCTION;
THORACIC AORTA;
TREATMENT OUTCOME;
ANIMALS;
AORTA, THORACIC;
APOLIPOPROTEINS E;
ARTERIOSCLEROSIS;
DISEASE MODELS, ANIMAL;
DISEASE PROGRESSION;
DNA, COMPLEMENTARY;
ELECTROPORATION;
GENE THERAPY;
GLYCOPROTEINS;
INJECTIONS, INTRAMUSCULAR;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
INTERLEUKIN-18;
MALE;
MICE;
MICE, INBRED C57BL;
MICE, KNOCKOUT;
PHENOTYPE;
PLASMIDS;
SIGNAL TRANSDUCTION;
SINUS OF VALSALVA;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 2942551762
PISSN: None
EISSN: 15244571
Source Type: Journal
DOI: 10.1161/hh1901.098735 Document Type: Article |
Times cited : (366)
|
References (0)
|